May 25, 2021


Spotlight on ISN Activities: World Kidney Day


"ISN-IFKF Webinar: Spotlight on World Kidney Day - Prevention of Chronic Kidney Disease" will be broadcast on Thursday, June 10, 2021, at 4 p.m. CEST (convert to your time zone here).

Join an international lineup of speakers:
  • Social Risk Factors for CKD, Deidra Crews (USA)
  • CKD Prevention Programs, Philip Li (China)
  • CKD Care in Disadvantaged Populations, Guillermo Garcia Garcia (Mexico)

Get answers to your questions directly from these experts in the Q&A session that follows.

This is the third edition of the ISN ‘Spotlight Sessions,’ a series of free online exchanges broadcast throughout the year on the ISN Academy to highlight ISN initiatives in advocacy, research, and education.

Find out more about World Kidney Day here.

Kidney International Reports Celebrates Five Years of Presenting Outstanding Research in Nephrology

KIR The Kidney International Reports's (KIR) Jai Radhakrishnan, editor-in-chief, Sumit Mohan, deputy editor, and Radha McLean, executive editor, highlight the journal's significant role in disseminating valuable research in nephrology, having published over 1,000 articles since its launch in 2016.
The article, 5 Years (And Counting) of Expanding Access to Kidney Disease Research, marking the fifth anniversary of the journal, presents its strengths and continuing growth, notably its successful open-access policy and the receipt of a first impact factor, 3.374, issued in 2020.

KIR expanded its editorial team in 2021 in line with a marked increase in submissions. In addition, “Regional Reports” have been added to the journal's repertoire, and "Research Letter" publications extended to include condensed format studies.

Unsurprisingly, KIR has published dozens of research articles, clinical trials, systematic reviews, and commentaries on the epidemiology and treatment of COVID patients with AKI and ESRD.

KIR continues to analyze changing readership patterns and innovate solutions to accommodate their needs, particularly within the social media landscape. It is dedicated to continuing to pioneer to provide the highest standards of research in kidney conditions and care.



Only One Week Left to Apply for an ISN-KI Editorial Fellowship

ISN-KI-fellowship The ISN and Kidney International (KI) are accepting expressions of interest from early-career nephrologists and scientists working in nephrology, dialysis, and transplantation for two positions as ISN-KI Editorial Fellows in 2021-2023.
The deadline is June 1, 2021.

Find out more on ISN-KI Editorial Fellowships, including eligibility criteria here.

ISN-ANIO India Committee Promotes ANIO Webinar Focused on Kidney Disease and Vascular Risk in South Asians

ISN-KI-fellowship The ISN-ANIO India Committee is a partnership between the International Society of Nephrology (ISN), the American Nephrologists of Indian Origin (ANIO) and other nephrologists of the Indian Diaspora, and works in partnership with the Indian Society of Nephrology.

The ISN-ANIO India Committee supports its partner ANIO’s webinar on June 7, 2021 at 5:30 p.m. PST /
8:30 p.m. EST.

ISN-ANIO member Nisha Bansal will present ‘Assessment of kidney function in South Asian populations.’ Alka Kanaya will present ‘Kidney and cardiometabolic disease risk factors in South Asians (data from the MASALA study).’ And Tazeen Jafar will present ‘Hypertension management in the South Asian populations.’

Senegal to Inaugurate Largest Dialysis Center in Western Africa


The ISN is pleased to share that Senegal will soon have the largest dialysis unit in Western Africa. The ISN Dialysis Working Group chair, Abdou Niang, recently presented the project to Senegal’s President, Macky Sall.

This brand-new unit will be part of the four-story Dalal Jamm Hospital in Dakar. This major referral hospital receives patients who are unable to access treatment elsewhere in the country.

Get Inspired by the ISN@Work Gallery on the WCN’21 Platform


Viviane Calice-Silva, from Brazil, was awarded an ISN Clinical Research Grant in 2014. This grant allowed her to investigate the use of salivary urea nitrogen (SUN) dipsticks for acute kidney injury detection in areas with low diagnostic resources.

Her study was later replicated in Africa, and different steps of the project have been published in separate papers. She continues to work alongside a team in Africa on various research projects. She says, "SUN strips are still under study, and we believe their application in special settings can improve AKI detection."

Viviane is one of the hundreds of ISN members dedicating time and energy to advancing worldwide kidney health, together. Read more inspiring accounts in the ISN@Work Gallery on the WCN'21 platform until May 31, 2021.



International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020 - Slide Deck and User Guide

International-Consensus-Definitions In October 2020, Kidney International published the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020 developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, earlier that year.
The final definitions, discussed in detail in the report, reflect the consensus for use in clinical trials.

The paper has been summarized into a slide deck and user guide for developing clinical trial protocols.

Access the slide deck and user guide here and share with your network.

ISN Global Trials Focus: May 2021


Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world.


A summary of the highlighted trial is now available in French, Mandarin, Russian, and Spanish.
See the latest trials here.

Support equal access to nephrology research, Become an ISN Member!


ISN Participates

Join Us for the ISN Joint Session at the ERA-EDTA Congress


The ISN is pleased to participate in the upcoming virtual ERA-EDTA Congress from June 5-8, 2021.

The ISN President, Agnes Fogo, will present a talk at 4 p.m. in the session “Improved Clarity of Definitions and Classification of Glomerular Lesions in Lupus Nephritis,” from 3-4.30 p.m. CEST on Monday, June 7.

Do join us at the ISN virtual booth at this event - we look forward to welcoming you there.


Share your Experience with Women in Nephrology (WIN)

Women in Nephrology (WIN) is curious to hear your feedback about your experience, as a member or non-member, about their initiatives and programs and what you would like to see WIN do in the future.
WIN is curious to hear your feedback about your experience, as a member or non-member, about their initiatives and programs and what you would like to see WIN do in the future.

13th International Podocyte Conference: July 27-31, 2021 -
The University of Manchester, UK & Online


Save the date for the 13th International Podocyte meeting, open to participants from all over the world.

There will be 3 sections to the meeting as follows:

  1. Pre-meeting focused on early career researchers (Tuesday, July 27)
  2. Main meeting: Bridging basic and translational research (Wednesday, July 28 - Friday, July 30)
  3. Patient-focused meeting: Communicating research (Saturday, July 31)

The ISN President, Agnes Fogo will be participating in the pre-meeting section.

The event offers free registrations to low and middle income countries.

Read more here.


Young Nephrologists

Looking to the Future: New YNC Leadership Shares Current Projects


YNC Chair Marina Wainstein and Deputy Chair Sabine Karam

The Young Nephrologists Committee (YNC) was launched in 2007 to understand and evaluate the needs of young nephrologists worldwide to develop opportunities for them within the ISN.

In the year ahead, we will explore the creation of a YN forum on the ISN website, hosted and moderated by the YNC, to discuss general topics and clinical dilemmas of current concern. In response to the increasing interest from YNs to join and engage with the committee, we plan to introduce a broader network to harness this enthusiasm.

The future looks bright, with many endeavors already established, such as the ELP program, grants for scientific writing, and continuous renal replacement therapy courses, or underway, such as contributing to developing the ISN mentorship program and stronger ties with Kidney International. We look forward to more capacity building and a greater contribution from the YNs toward ISN's mission and vision to advance kidney health worldwide-together.



Explore and Use the ISN Framework for Developing Dialysis Programs in Low-resource Settings


The "ISN Framework for Developing Dialysis Programs in Low-resource Settings" outlines the requirements and operational considerations for setting up or expanding dialysis programs and developing sustainable strategies to treat patients with kidney failure.

The framework, developed in collaboration with the World Health Organization (WHO) in ISN's official capacity as a WHO non-state actor, reflects a commitment to support health systems worldwide to develop resource-sensitive solutions to care for kidney disease patients in low-resource settings.

Read more on this initiative in "Bringing equity in access to quality dialysis," published in The Lancet.

ISN President Places Patients at Center of ISN's Mission at Global Summit


On May 13, the ISN President, Agnes Fogo, spoke at the Third Annual Global Summit on Kidney Innovation: Expanding Patient Choices and Outcomes, organized by the American Association of Kidney Patients and the George Washington University, hosted virtually from May 13-14, 2021.

Watch Agnes Fogo’s presentation here.
As a leader in the global kidney space, Agnes Fogo stressed vital role that kidney patients play in research and innovation in the session, “International Kidney Innovations Consortium: International Organizations Working in the Space Provide Global Perspectives.” In addition, she outlined how the ISN would help drive change by empowering local communities and supporting fledgling patient groups in lower and middle-income countries.


Help Expand Trial Participation in Nephrology: Join Colleagues Online for the #NephTrials Debate


The #NephTrials initiative is an exciting series of conversations combining expertise from the ISN-ACT Global Trials Focus, the ISN-ACT Toolkit, and the #NephJC community.

Join the latest #NephTrials discussion on May 25 at 9 p.m. ET.

The conversation will focus on DIAL-MAG, which evaluates the effect of increased magnesium concentration in dialysate on the risk of dialysis patients dying or being hospitalized due to heart issues.

The hosts welcome expert testimony, lively debate, and new ideas from people with diverse needs, interests, and skills.

To access the conversation: Follow @NephJC, type “NephTrials” in Twitter’s search bar, go to “latest,” and "follow" the conversation #NephTrials #NephJC

Upcoming Webinars

Thursday, May 27, 3 p.m. CEST

@ISNeducation Webinar:
COVID Vaccination in Immune-mediated Kidney Diseases

Speaker: Kültigin Türkmen, Turkey
Moderator: Francesco Iannuzzella, Italy
quiz.png?dl=0 Take the @ISNeducation Quiz on this topic.
Quiz by Divya Bajpai, Didem Turgut, Basu Gopal, and
Grace Igiraneza
Friday, June 18, 3 p.m. CEST

ISN-KDIGO Webinar:
Central and Peripheral Arterial Diseases in CKD

Speakers: Dearbhla Kelly, Ireland
Pantelis Sarafidis, Greece
Moderator: Charles Herzog, USA


Support Those Affected by the COVID-19 Crisis in India


Nakul Agarwal, a recent university graduate currently working in the U.S., has started a small fundraising initiative to support a verified charity (Hemkunt Foundation) helping the poor and needy in India who do not have access to or cannot afford COVID-related resources.

Kidney International (KI) on COVID-19


Kidney International Reports (KIR) on COVID-19


Kidney International Editorial Selection

Kidney Disorders as Serious Adverse Drug Reactions of Remdesivir in Covid-19: A Retrospective Case-noncase Study


Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In clinical trials and case series, acute kidney injury (AKI), including renal replacement, has been frequently reported.

Although causality is debatable, kidney injuries, especially proximal tubular epithelial cell necrosis, have also been observed in animal studies during remdesivir development.

Results demonstrate an increased reporting of kidney disorders using remdesivir compared with the use of chloroquine, hydroxychloroquine, dexamethasone, sarilumab, or tocilizumab.